Literature DB >> 16251424

Stromal regulation of neoplastic development: age-dependent normalization of neoplastic mammary cells by mammary stroma.

Maricel V Maffini1, Janine M Calabro, Ana M Soto, Carlos Sonnenschein.   

Abstract

There is mounting evidence that the stroma plays a crucial role in mammary gland carcinogenesis. Here, we report that mammary gland stroma from mature and multiparous rats prevents neoplastic development and encourages normal ductal growth of grafted epithelial cancer cells. Fifty thousand epithelial cancer cells were injected into the cleared fat pads of virgin hosts at 24, 52, 80, and 150 days of age and of hosts that had undergone two cycles of pregnancy, lactation, and involution. Six months after inoculation, tumor incidence was 75%, 100%, 50%, and 18.2% in 24-, 52-, 80-, and 150-day-old virgin rats, respectively, and 0% in the twice-parous animals. Most remarkably, these neoplastic cells appeared to form normal ducts in all hosts-Ha-ras-1 mutation served as a marker to identify the tumor origin of the outgrowths. The tumor development pattern suggests a parallel to the phenomenon of age- and reproductive state-dependent susceptibility and resistance to chemical carcinogens. As susceptibility to carcinogenesis decreases, the ability of the stroma to reprogram neoplastic epithelial cells increases. Thus, the neoplastic phenotype is context-dependent, and it therefore offers the intriguing possibility that the process of carcinogenesis is amenable to normalization or cure once the mechanisms of stroma-mediated normalization are elucidated and manipulated.

Entities:  

Mesh:

Year:  2005        PMID: 16251424      PMCID: PMC1603788          DOI: 10.1016/S0002-9440(10)61227-8

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  41 in total

1.  ras gene mutations are absent in NMU-induced mammary carcinomas from aging rats.

Authors:  T A Thompson; J D Haag; M N Gould
Journal:  Carcinogenesis       Date:  2000-10       Impact factor: 4.944

2.  Malignant transformation in a nontumorigenic human prostatic epithelial cell line.

Authors:  S W Hayward; Y Wang; M Cao; Y K Hom; B Zhang; G D Grossfeld; D Sudilovsky; G R Cunha
Journal:  Cancer Res       Date:  2001-11-15       Impact factor: 12.701

3.  Morphostats: a missing concept in cancer biology.

Authors:  J D Potter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-03       Impact factor: 4.254

Review 4.  Stromal effects on mammary gland development and breast cancer.

Authors:  Bryony S Wiseman; Zena Werb
Journal:  Science       Date:  2002-05-10       Impact factor: 47.728

5.  Somatic mutation theory of carcinogenesis: why it should be dropped and replaced.

Authors:  C Sonnenschein; A M Soto
Journal:  Mol Carcinog       Date:  2000-12       Impact factor: 4.784

Review 6.  Timing of exposure and mammary cancer risk.

Authors:  Coral A Lamartiniere
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-01       Impact factor: 2.673

7.  The stroma as a crucial target in rat mammary gland carcinogenesis.

Authors:  Maricel V Maffini; Ana M Soto; Janine M Calabro; Angelo A Ucci; Carlos Sonnenschein
Journal:  J Cell Sci       Date:  2004-03-02       Impact factor: 5.285

Review 8.  Role of the stromal microenvironment in carcinogenesis of the prostate.

Authors:  Gerald R Cunha; Simon W Hayward; Y Z Wang; William A Ricke
Journal:  Int J Cancer       Date:  2003-10-20       Impact factor: 7.396

9.  Watch thy neighbor: cancer is a communal affair.

Authors:  Valerie M Weaver; Penney Gilbert
Journal:  J Cell Sci       Date:  2004-03-15       Impact factor: 5.285

10.  Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1990.

Authors:  Charles E Land; Masayoshi Tokunaga; Kojiro Koyama; Midori Soda; Dale L Preston; Issei Nishimori; Shoji Tokuoka
Journal:  Radiat Res       Date:  2003-12       Impact factor: 2.841

View more
  60 in total

1.  Fractal analysis in a systems biology approach to cancer.

Authors:  M Bizzarri; A Giuliani; A Cucina; F D'Anselmi; A M Soto; C Sonnenschein
Journal:  Semin Cancer Biol       Date:  2011-04-13       Impact factor: 15.707

2.  Tumour development due to stroma permissiveness.

Authors:  Edna Cukierman
Journal:  J Biosci       Date:  2005-12       Impact factor: 1.826

3.  Induction of mammary gland ductal hyperplasias and carcinoma in situ following fetal bisphenol A exposure.

Authors:  Tessa J Murray; Maricel V Maffini; Angelo A Ucci; Carlos Sonnenschein; Ana M Soto
Journal:  Reprod Toxicol       Date:  2006-10-24       Impact factor: 3.143

4.  Carcinogenesis and metastasis now in the third dimension--what's in it for pathologists?

Authors:  Carlos Sonnenschein; Ana M Soto
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

Review 5.  Theories of carcinogenesis: an emerging perspective.

Authors:  Carlos Sonnenschein; Ana M Soto
Journal:  Semin Cancer Biol       Date:  2008-03-26       Impact factor: 15.707

Review 6.  Three-dimensional context regulation of metastasis.

Authors:  Janine T Erler; Valerie M Weaver
Journal:  Clin Exp Metastasis       Date:  2008-09-24       Impact factor: 5.150

7.  Cancer Metastases: So Close and So Far.

Authors:  Carlos Sonnenschein; Ana M Soto
Journal:  J Natl Cancer Inst       Date:  2015-08-17       Impact factor: 13.506

Review 8.  Control of cancer formation by intrinsic genetic noise and microenvironmental cues.

Authors:  Amy Brock; Silva Krause; Donald E Ingber
Journal:  Nat Rev Cancer       Date:  2015-07-09       Impact factor: 60.716

9.  The microenvironment determines the breast cancer cells' phenotype: organization of MCF7 cells in 3D cultures.

Authors:  Silva Krause; Maricel V Maffini; Ana M Soto; Carlos Sonnenschein
Journal:  BMC Cancer       Date:  2010-06-07       Impact factor: 4.430

10.  Staged stromal extracellular 3D matrices differentially regulate breast cancer cell responses through PI3K and beta1-integrins.

Authors:  Remedios Castelló-Cros; David R Khan; Jeffrey Simons; Matthildi Valianou; Edna Cukierman
Journal:  BMC Cancer       Date:  2009-03-26       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.